For Q1FY26, Apollo Hospitals' consolidated revenue grew 15 per cent year-on-year (Y-o-Y) to ₹5,842 crore, driven by all three business segments.
Apollo Hospitals shares rose 6 per cent after it reported a 42 per cent surge in its June quarter net profit
Apollo Hospitals posted a 42% rise in Q1 net profit to Rs 432.8 crore and announced a Rs 7,600 crore investment plan to add over 4,300 beds in five years
F&O stocks: For Apollo Hospitals, the short-term trend is positive as it is placed above its 5, 11 and 20-day EMA.
Stocks to buy: Analyst at Religare recommends Sun Pharma, Apollo Hospitals; Check target price, stop loss here
Apollo AyurVAID, one of India's largest Ayurvedic hospital chains, targets 1,000 beds and Rs 500 crore turnover by 2028, as demand for Ayurvedic treatments rises
With significant untapped market opportunities and a shortage of healthcare infrastructure in India, leading Indian companies have immense potential for expansion.
New entity combining Apollo 24/7, HealthCo, and Keimed aims for Rs 25,000 crore revenue by FY27 with 7% EBITDA margin; IPO planned in 18-21 months
Apollo Hospitals surged over 4 per cent on plans to spin off and separately list its digital health and pharmacy unit
The hospital operator will retain a 15 per cent stake in the entity, which it is yet to be named, and will also have its nominee on the board of the new company